Wells Fargo analyst Larry Biegelsen raised the firm’s price target on GE HealthCare (GEHC) to $103 from $96 and keeps an Overweight rating on the shares. The firm notes GE HealthCare delivered organic growth of about 2%, while EPS beat consensus and Wells Fargo’s estimates. Given China headwinds, management expects China to decline in the first half of the year, grow in the second half and be down low single digit for 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Positive Outlook for GE Healthcare Technologies Inc.: Buy Rating Supported by Strong EPS Performance and Strategic Growth Initiatives
- GE HealthCare Reports Revenue Growth and Margin Expansion
- GE HealthCare price target raised to $110 from $103 at Citi
- Cisco jumps after earnings beat, Trump teases reciprocal tariffs: Morning Buzz
- Strong Buy Recommendation for GE Healthcare Technologies Inc. Amid Promising Financial Performance and Growth Prospects